Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSE
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 325 participants.
Also called NCT07902739
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 325 participants
- Registry
-
NCT07902739
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia
- Registry status
- Completed
Technical summary
Registry record NCT07902739. Randomized; no masking; primary purpose treatment. Start 2024-05-17 (actual); primary completion 2026-10-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSE
- Condition
- Atrial Fibrillation (AF)
- Condition
- Paroxysmal AF
- Condition
- Persistent AF
- Intervention (Device)
- CENTAURI PEF system
- Intervention (Device)
- FARAPULSE system
- Lead sponsor
- St. Anne's University Hospital Brno, Czech Republic
Record details
- Record id
cardio:ct-nct07902739- Content hash
f9926b3639ca9e38fe72a8995e3bf3c13a7595fb7af04a06e85fac88644891e7